SCHEMBL6408900

SCHEMBL6408900

COC(=O)NC(CCN1CCC2(CC1)CCN(Cc1ccc(Br)cc1)C2=O)c1cccs1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 5/20 0.38
CACNA2D1 P54289 4/20 0.36
OPRM1 P35372 1/20 0.35
OPRL1 P41146 1/20 0.35
HDAC11 Q96DB2 3/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
CYP2C19 P33261 1/20 0.34
SLC6A2 P23975 2/20 0.34
MMP1 P03956 2/20 0.34
MMP9 P14780 2/20 0.34
MMP13 P45452 2/20 0.34
ADAM17 P78536 2/20 0.34
LMNA P02545 1/20 0.34
HTR1A P08908 1/20 0.33
HSD11B1 P28845 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6408897 0.99 CCR5 (0.38) CCR5CACNA2D1OPRM1OPRL1HDAC11
SCHEMBL6416140 0.93 CCR5 (0.38) CCR5CACNA2D1OPRM1OPRL1HDAC11
Hydrochloric Acid SCHEMBL6416135 0.92 CCR5 (0.38) CCR5CACNA2D1OPRM1OPRL1HDAC11
SCHEMBL6410431 0.92 CCR5 (0.36) CCR5CACNA2D1HDAC11SLC6A2
SCHEMBL6410548 0.92 MMP1 (0.40) CCR5CACNA2D1OPRM1OPRL1ALOX15
SCHEMBL6415315 0.91 CCR5 (0.38) CCR5CACNA2D1HDAC11SLC6A2MMP1
Hydrochloric Acid SCHEMBL6410546 0.91 MMP1 (0.39) CCR5CACNA2D1OPRM1OPRL1SLC6A2
SCHEMBL5249978 0.91 CCR5 (0.40) CCR5CACNA2D1HDAC11TSHRLMNA
Hydrochloric Acid SCHEMBL6408374 0.90 CCR5 (0.38) CCR5CACNA2D1HDAC11SLC6A2MMP1
SCHEMBL6414679 0.90 CCR5 (0.40) CCR5CACNA2D1OPRM1OPRL1HDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050075326-A1 Spiro compounds and methods for the modulation of chemokine receptor activity VIROCHEM PHARMA INC (CA) 2005-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050075326-A1 Spiro compounds and methods for the modulation of chemokine receptor activity CXCR1, CXCR4, CXCR2 CCR5 4/4885CACNA2D1 3593/4885OPRM1 244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.